Video Latest - ecancer

Molecular pathways associated with immune modulation and thalidomide analogues

Dr Rajesh Chopra - Vice President of Translational and Early Drug Development, Celgene

25 Mar 2014

Dendritic cell vaccination combined with CTLA4 blockade

Dr Kris Thielemans - Medical School of the VUB, Brussels, Belgium

25 Mar 2014

mRNA-based cancer vaccines

Dr Karl-Josef Kallen - Principal Scientific Fellow, CureVac Gmbh

24 Mar 2014

Immuno-biological properties of human cancer stem cells

Dr Cristina Maccalli - NIBIT (Italian Network for Biotherapy of Tumours), Siena, Italy

24 Mar 2014

Novel CEA-targeted IL2 variant immunocytokine for immunotherapy of cancer

Dr Christian Klein - Head of Oncology Programs, Discovery Oncology, Roche Pharma Research and Early Development, Roche Glycart AG, Schlieren, Switzerland

24 Mar 2014

Mechanisms of action and robotics in mCRPC

Dr Anthony Ng Chi-Fai - University of Hong Kong, Hong Kong, China

21 Mar 2014

mCRPC management in Taiwan - expert interview

Prof Paul de Souza and Dr Wayne Yen-Hwa Chang

21 Mar 2014

Cost constraints affect treatment decision-making in China and Singapore - expert discussion

Prof Kurt Miller, Dr Li-qun Zhou and Dr Ravindran Kanesvaran

21 Mar 2014

Insights into mCRPC in China, Thailand and Indonesia - expert discussion

Prof Rainy Umbas, Prof Narin Voravud and Prof Li Ping Xie

21 Mar 2014

The future of mCRPC treatment - expert discussion

Prof Li Ping Xie - Zhejiang University School of Medicine, Hangzhou, China and Prof Paul de Souza - University of Western Sydney, Sydney, Australia

21 Mar 2014

Sharing Indian perspectives on CRPC

Dr Senthil Rajippa - Kidwai Memorial Institute of Oncology, Bangalore, India

21 Mar 2014

ecancermedicalscience Editor's Choice for March 2014

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy

18 Mar 2014

Video

More from ecancer